Araris Biotech Ag

Araris Biotech Ag company information, Employees & Contact Information

Updated May 2026

Quick answer

Araris Biotech Ag is a Biotechnology Research company and founded in 2019. It has approximately 20 employees on record. Contact data was last refreshed in May 2026. Find Araris Biotech Ag's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.

Company Details

Employees
20
Founded
2019
Address
Riedhofstrasse 11, Au,zh 8804,switzerland
Phone
+41 56 310 45 98
Email
in****@****ech.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Au, ZH
Looking for a particular Araris Biotech Ag employee's phone or email?

Araris Biotech Ag Questions

News

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech - GlobeNewswire

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech GlobeNewswire

Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology - GlobeNewswire

Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology GlobeNewswire

Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate Platform in ChemBioChem - Yahoo Finance

Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate Platform in ChemBioChem Yahoo Finance

Araris Biotech acquired by Taiho Pharmaceutical to accelerate ADC drug discovery - Venturelab Swiss

Araris Biotech acquired by Taiho Pharmaceutical to accelerate ADC drug discovery Venturelab Swiss

One-Step ADC Linker Approach Bypasses Antibody Engineering - Genetic Engineering and Biotechnology News

One-Step ADC Linker Approach Bypasses Antibody Engineering Genetic Engineering and Biotechnology News

Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic - Fierce Biotech

Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic Fierce Biotech

Araris Biotech achieves unicorn status - Switzerland Global Enterprise

Araris Biotech achieves unicorn status Switzerland Global Enterprise

Schroders Capital Global Innovation’s Araris Biotech sold to Taiho Pharmaceutical - QuotedData

Schroders Capital Global Innovation’s Araris Biotech sold to Taiho Pharmaceutical QuotedData

New ADC Linker Tech Shows Efficacy, Safety Advantages - Bioprocess Online

New ADC Linker Tech Shows Efficacy, Safety Advantages Bioprocess Online

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion - GlobeNewswire

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion GlobeNewswire

Araris Biotech AG Expands its IP Portfolio with the - GlobeNewswire

Araris Biotech AG Expands its IP Portfolio with the GlobeNewswire

Top Araris Biotech Ag Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant